Can a simple flu shot protect transplant patients?
NCT ID NCT01086904
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested an inactivated H1N1 flu vaccine in 122 kidney transplant recipients who were at least 6 months post-transplant and on triple immunosuppression. The goal was to see if the vaccine could safely trigger an immune response. Researchers measured antibody levels and tracked side effects over several months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- inactivated non-adjuvanted pandemic H1N1 influenza vaccine
- What this could lead to
- If successful, this could show that a standard flu vaccine can safely protect kidney transplant patients, who are at higher risk from flu.
- What could go wrong
- This is a small, completed phase 2 trial, so results may not apply to all transplant patients. The vaccine may not trigger a strong enough immune response due to their immunosuppressant drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOSUPPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier Lyon Sud, service de néphrologie transplantation
Pierre-Bénite, Lyon, 69495, France
-
Hôpital E. Herriot , Service de néphrologie, transplantation et immunologie clinique
Lyon, 69437, France
-
Service d'urologie, GH Pitié Salpêtrière
Paris, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo shield young hearts from transplant complications?
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
- Scientists probe immune cell shifts in ICU patients to unlock sepsis secrets
- Can a new drug help sepsis patients with weak immune systems?
- Could a single cell infusion replace lifelong Anti-Rejection drugs?
- Can the shingles vaccine protect transplant patients? new study aims to find out